Glimepiride 2mg

Antidiabetic Agent, Sulfonylurea

CSA NA – FDA Approved – REMS (N) – Can Ship

Glimepiride, Amaryl is a sulfonylurea that stimulates the pancreatic beta cells to release insulin, reduces glucose output from the liver and increases insulin sensitivity.

Diabetes mellitus, Type 2

Before starting Glimepiride, Amaryl make sure your physician is aware of any allergies or medications you currently take.  As with many other hypoglycemic drugs, sulfonylureas can cause hypoglycemia and weight gain.

Oral: Take 4mg to 8mg daily in divided doses.

Take with breakfast or your first main meal of the day.

Hypoglycemia, dizziness, headache, nausea, accidental injury.

Note this is not a complete list of side effects for Glimepiride, Amaryl only common ones.

1. What is hypoglycemia?
   Hypoglycemia is a condition of low blood sugar (>3.9mmol/L-Canada; 70mg/dL-US) which is considered a medical emergency whereas hyperglycemia is a slow progressive condition.  It generally occurs with irregularities in diet, exercise, and medications in diabetic patients.  It is preferably treated with simple sugars such as dextrose; regular table sugar can work but is slower acting as it needs to be digested and if blood sugar is extremely low this delay can be a problem. Hypoglycemia has a large host of progressive symptoms from hunger, headache, nausea, sweating, palpitations, mood swings, irritability to seizure, coma and in severe cases, death.